Research and development services
Ended Definitive Contract Awarded Last action
- Contract number
- HT942524C0111
- Awardee
-
The Geneva Foundation UEI TR9RX33188T4
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $561,042
Award facts
- Opportunity
-
- HT942524R0105 Solicitation number
- Contract value 100% obligated
- $561,042.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- USAF DFAS Air Force, Department of Defense
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Tacoma, WA 98402, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $561,042 |
About this award
The U.S. Air Force Defense Finance and Accounting Service awarded a $561,042 firm fixed-price definitive contract to The Geneva Foundation, a Tacoma, Washington-based nonprofit specializing in military medical research and development. The contract, effective through September 29, 2026, funds a research study investigating the therapeutic effects of NVG-291, a protein tyrosine phosphatase inhibitor, on sensorineural hearing loss resulting from blast-induced auditory injury. This research addresses a significant health concern for military personnel exposed to combat-related acoustic trauma. The work will be performed in Tacoma, Washington, and the contract carries no set-aside designation.
The Geneva Foundation has engaged the Metis Foundation, a San Antonio-based nonprofit with extensive experience in military medical research support, as a subcontractor on the project. Both organizations bring established track records collaborating with military medical facilities and federal health agencies on biomedical research initiatives. The Geneva Foundation's portfolio includes advanced medical research across infectious disease, combat trauma, and therapeutic development, while Metis Foundation provides specialized research coordination and scientific support services. This collaboration leverages complementary capabilities to advance research on hearing loss mitigation, contributing to improved healthcare outcomes for service members.
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| Michigan State University | $125,000 | |
| Metis Foundation | $90,767 |
Quick answers
Who was awarded contract HT942524C0111?
HT942524C0111 was awarded to The Geneva Foundation by Defense Health Agency (Department of Defense) on September 30, 2024.
How much is contract HT942524C0111 worth?
The government has obligated $561,042 on HT942524C0111.
Which agency awarded contract HT942524C0111?
Defense Health Agency (Department of Defense) awarded HT942524C0111, with funding from USAF DFAS (Air Force).
Was contract HT942524C0111 competed?
The extent of competition for HT942524C0111 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award